-
| CurrencyCode | USD |
|---|---|
| Industry | Medical Devices |
| Exchange | NASDAQ |
| Sector | Healthcare |
| ISIN | US00902F1057 |
| Market Cap | 10M |
|---|---|
| Beta | 2.22 |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women's health. In addition, it develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases, plus applications in animal health. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AIMD using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025